Opella Hispanic Latin America

Certified B Corporation
Standards version

1.6

Headquarters

Mexico City, Mexico

Certified Since

December 2023

Industry

Pharmaceutical products

Sector

Manufacturing

Operates In

Argentina,

Aruba,

Bahamas The,

Barbados,

Belize,

Bolivia,

Cayman Islands,

Chile,

Colombia,

Costa Rica,

Ecuador,

El Salvador,

Guatemala,

Honduras,

Jamaica,

Mexico,

Nicaragua,

Panama,

Paraguay,

Peru,

Saint Vincent and the Grenadines,

Uruguay,

Venezuela

Opella Hispanic Latin America (Sanofi-aventis de Mexico, Opella Healthcare Colombia, Opella Healthcare Ecuador, Opella Healthcare Panama, Opella Healthcare Peru, Opella Healthcare Argentina) offers a diverse product line of over-the-counter medicines across several categories, including: allergy, digestive health, cough, cold and dietary supplements. Through our consumer-led, science-based products we enable people to champion better self-care and are investing in community well-being, because we believe healthier people and a healthier planet go hand in hand. Sanofi Consumer Healthcare Hispanic Latin America earned B Corp Certification because of its continued commitment to social impact and sustainability. For more information, visit: https://www.sanofi.com/en/your-health/consumer-healthcare/sustainability-at-sanofi-consumer-healthcare

Overall B Impact Score

Based on the B Impact assessment, Opella Hispanic Latin America earned an overall score of 83.4. The median score for ordinary businesses who complete the assessment is currently 50.9.
83.4
83.4 Overall B Impact Score
80 Qualifies for B Corp Certification
50.9 Median Score for Ordinary Businesses

Governance 11.9


Workers 26.0


Community 15.3


Environment 14.3


Customers 15.6



Additional Documentation

Sanofi CHC Hispanic Latin America Disclosure Report 2023

Sanofi Consumer Healthcare SOCOPAC_Transparent Assessment 2023

Sanofi Consumer Healthcare Mexico_Transparent Assessment 2023

Sanofi CHC Hispanic Latin America - B Lab Statement Pharmaceutical Industry Disclosure (2023)

Sanofi CHC Hispanic Latin America - Score Aggregation Methodology (2023)